CPT is a rare and challenging condition characterized by dysplasia of the tibia leading to anterolateral bowing and risk of pathological fracture. While the exact etiology is unclear, it may involve a defect in the NF1 gene. There is no consensus on treatment, but established methods achieving union rates over 70% include intramedullary rodding, Ilizarov external fixation, and vascularized fibular grafting. The Ilizarov technique and BMP augmentation may further improve outcomes, though long-term results of newer approaches are still unknown. CPT remains difficult to treat and sometimes amputation is considered.